Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-(3-methoxyphenyl)-3-oxododecanamide
ID: ALA5278377
Max Phase: Preclinical
Molecular Formula: C19H29NO3
Molecular Weight: 319.44
Associated Items:
ID: ALA5278377
Max Phase: Preclinical
Molecular Formula: C19H29NO3
Molecular Weight: 319.44
Associated Items:
Canonical SMILES: CCCCCCCCCC(=O)CC(=O)Nc1cccc(OC)c1
Standard InChI: InChI=1S/C19H29NO3/c1-3-4-5-6-7-8-9-12-17(21)15-19(22)20-16-11-10-13-18(14-16)23-2/h10-11,13-14H,3-9,12,15H2,1-2H3,(H,20,22)
Standard InChI Key: GVEINJPJYHDHBR-UHFFFAOYSA-N
Molfile:
RDKit 2D 23 23 0 0 0 0 0 0 0 0999 V2000 -2.1447 0.8271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1447 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4302 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7158 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7158 0.8271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0014 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7130 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4274 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1418 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8563 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5708 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2852 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9996 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7141 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8592 -0.4103 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.5736 0.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2835 -0.4094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9997 -0.0015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9997 0.8267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2853 1.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5736 0.8271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7141 -0.4140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.7141 -1.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 15 2 1 0 16 15 1 0 17 16 1 0 18 17 2 0 19 18 1 0 20 19 2 0 21 20 1 0 16 21 2 0 18 22 1 0 22 23 1 0 M END
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 319.44 | Molecular Weight (Monoisotopic): 319.2147 | AlogP: 4.73 | #Rotatable Bonds: 12 |
Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.51 | CX Basic pKa: ┄ | CX LogP: 5.09 | CX LogD: 5.09 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.45 | Np Likeness Score: -0.42 |
1. Ampomah-Wireko M, Luo C, Cao Y, Wang H, Nininahazwe L, Wu C.. (2021) Chemical probe of AHL modulators on quorum sensing in Gram-Negative Bacteria and as antiproliferative agents: A review., 226 [PMID:34626877] [10.1016/j.ejmech.2021.113864] |
2. Wagner S, Sommer R, Hinsberger S, Lu C, Hartmann RW, Empting M, Titz A.. (2016) Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections., 59 (13): [PMID:26804741] [10.1021/acs.jmedchem.5b01698] |
Source(1):